Phytochemicals such as apigenin and quercetin have been shown to shift the balance toward apoptosis by downregulating antiapoptotic BCL‐2 family members and upregulating BAX in diverse cancer cell models, such as breast and PCa cell lines [46, 47, 48]. The gene discussed is BCL2; the disease is posterior cortical atrophy.